Construction and Testing of Two Distinct Humanized CD19-Specific Chimeric Antigen Receptors (CARs) for the Treatment of B-Cell Malignancies

被引：0

作者：

Gopalakrishnan, Ramakrishnan ^{[1
]}

Matta, Hittu ^{[1
]}

Choi, Sunju ^{[2
]}

Han, Xu ^{[2
]}

Prakash, Rekha ^{[2
]}

Narasappa, Nell ^{[2
]}

Gong, Songjie ^{[2
]}

Chitnis, Saurabh ^{[2
]}

Kahn, Michael ^{[2
]}

Sernas, Jennifer ^{[2
]}

Khan, Prottasha ^{[2
]}

Chaudhary, Preet ^{[2
]}

机构：

[1] Univ So Calif, Ctr Study Blood Dis, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA

[2] Univ So Calif, Los Angeles, CA 90033 USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.4025.4025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4025

引用

页数：4

共 50 条

[1] The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies
Tsukahara, T.
Iwase, N.
Kawakami, K.
Iwasaki, M.
Yamamoto, C.
Ohmine, K.
Uchibori, R.
Teruya, T.
Ido, H.
Saga, Y.
Urabe, M.
Mizukami, H.
Kume, A.
Nakamura, M.
Brentjens, R.
Ozawa, K.
GENE THERAPY, 2015, 22 (02) : 209 - 215
[2] The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies
T Tsukahara
N Iwase
K Kawakami
M Iwasaki
C Yamamoto
K Ohmine
R Uchibori
T Teruya
H Ido
Y Saga
M Urabe
H Mizukami
A Kume
M Nakamura
R Brentjens
K Ozawa
Gene Therapy, 2015, 22 : 209 - 215
[3] Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
Tsukahara, Tomonori
Ohmine, Ken
Uchibori, Ryosuke
Ido, Hiroyuki
Urabe, Masashi
Mizukami, Hiroaki
Kume, Akihiro
Nakamura, Masataka
Mineno, Junichi
Takesako, Kazutoh
Riviere, Isabelle
Sadelain, Michel
Brentjens, Renier
Ozawa, Keiya
MOLECULAR THERAPY, 2013, 21 : S248 - S249
[4] Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells
Chen, Xiaojuan
Wang, Ying
Ruan, Min
Li, Jun
Zhong, Mengjun
Li, Zhanqi
Liu, Fang
Wang, Shuchun
Chen, Yumei
Liu, Lipeng
Yang, Jun J.
Zhu, Xiaofan
Wang, Jianxiang
Pui, Ching-Hon
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06): : 366 - 370
[5] Fully human CD19-specific chimeric antigen receptors for T-cell therapy
Sommermeyer, D.
Hill, T.
Shamah, S. M.
Salter, A. I.
Chen, Y.
Mohler, K. M.
Riddell, S. R.
LEUKEMIA, 2017, 31 (10) : 2191 - 2199
[6] Fully human CD19-specific chimeric antigen receptors for T-cell therapy
D Sommermeyer
T Hill
S M Shamah
A I Salter
Y Chen
K M Mohler
S R Riddell
Leukemia, 2017, 31 : 2191 - 2199
[7] Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia
Cao, Jiang
Cheng, Hai
Qi, Kunming
Chen, Wei
Shi, Ming
Zheng, Junnian
Xu, Kailin
BLOOD, 2019, 134
[8] Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia
Cao, Jiang
Cheng, Hai
Shi, Ming
Wang, Gang
Chen, Wei
Qi, Kunming
Li, Huizhong
Qiao, Jianlin
Zhao, Jing
Wu, Qingyun
Zeng, Lingyu
Jing, Guangjun
Zheng, Junnian
Xu, Kailin
LEUKEMIA, 2019, 33 (11) : 2751 - 2753
[9] Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia
Jiang Cao
Hai Cheng
Ming Shi
Gang Wang
Wei Chen
Kunming Qi
Huizhong Li
Jianlin Qiao
Jing Zhao
Qingyun Wu
Lingyu Zeng
Guangjun Jing
Junnian Zheng
Kailin Xu
Leukemia, 2019, 33 : 2751 - 2753
[10] Therapy of B Cell Malignancies with CD19-Specific Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
Turtle, Cameron J.
Sommermeyer, Daniel
Berger, Carolina
Hudecek, Michael
Shank, David M.
Steevens, Natalia N.
Budiarto, Tanya M.
Karimi, Mandana
Chaney, Colette N.
DeVito, Anna Marie
Heimfeld, Shelly
Jensen, Michael C.
Riddell, Stanley R.
Maloney, David G.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →